nodes	percent_of_prediction	percent_of_DWPC	metapath
Bezafibrate—HMGCR—atherosclerosis	0.161	0.407	CbGaD
Bezafibrate—PPARA—atherosclerosis	0.158	0.401	CbGaD
Bezafibrate—HMGCR—Rosuvastatin—atherosclerosis	0.0849	0.194	CbGbCtD
Bezafibrate—HMGCR—Simvastatin—atherosclerosis	0.0789	0.181	CbGbCtD
Bezafibrate—HMGCR—Pravastatin—atherosclerosis	0.0772	0.177	CbGbCtD
Bezafibrate—HMGCR—Lovastatin—atherosclerosis	0.0772	0.177	CbGbCtD
Bezafibrate—PPARG—atherosclerosis	0.0757	0.192	CbGaD
Bezafibrate—SLCO1B1—Rosuvastatin—atherosclerosis	0.0176	0.0404	CbGbCtD
Bezafibrate—SLCO1B1—Ezetimibe—atherosclerosis	0.0176	0.0404	CbGbCtD
Bezafibrate—SLCO1B1—Simvastatin—atherosclerosis	0.0164	0.0375	CbGbCtD
Bezafibrate—SLCO1B1—Pravastatin—atherosclerosis	0.016	0.0367	CbGbCtD
Bezafibrate—SLCO1B1—Lovastatin—atherosclerosis	0.016	0.0367	CbGbCtD
Bezafibrate—CYP2C8—Simvastatin—atherosclerosis	0.00694	0.0159	CbGbCtD
Bezafibrate—CYP2C8—Lovastatin—atherosclerosis	0.00679	0.0155	CbGbCtD
Bezafibrate—CYP2C8—Pravastatin—atherosclerosis	0.00679	0.0155	CbGbCtD
Bezafibrate—CYP3A4—Rosuvastatin—atherosclerosis	0.00303	0.00693	CbGbCtD
Bezafibrate—CYP3A4—Ezetimibe—atherosclerosis	0.00303	0.00693	CbGbCtD
Bezafibrate—CYP3A4—Simvastatin—atherosclerosis	0.00281	0.00644	CbGbCtD
Bezafibrate—CYP3A4—Lovastatin—atherosclerosis	0.00275	0.0063	CbGbCtD
Bezafibrate—CYP3A4—Pravastatin—atherosclerosis	0.00275	0.0063	CbGbCtD
Bezafibrate—PPARG—leg—atherosclerosis	0.00214	0.115	CbGeAlD
Bezafibrate—PPARG—hindlimb—atherosclerosis	0.00191	0.102	CbGeAlD
Bezafibrate—PPARA—blood vessel—atherosclerosis	0.00166	0.089	CbGeAlD
Bezafibrate—PPARG—appendage—atherosclerosis	0.00164	0.0879	CbGeAlD
Bezafibrate—Myositis—Rosuvastatin—atherosclerosis	0.00153	0.0199	CcSEcCtD
Bezafibrate—Creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00142	0.0186	CcSEcCtD
Bezafibrate—Creatine phosphokinase increased—Lovastatin—atherosclerosis	0.00121	0.0158	CcSEcCtD
Bezafibrate—Creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.00118	0.0155	CcSEcCtD
Bezafibrate—PPARG—artery—atherosclerosis	0.00117	0.0628	CbGeAlD
Bezafibrate—Creatine phosphokinase increased—Simvastatin—atherosclerosis	0.00113	0.0147	CcSEcCtD
Bezafibrate—Blood creatine phosphokinase increased—Rosuvastatin—atherosclerosis	0.00109	0.0142	CcSEcCtD
Bezafibrate—Transaminases increased—Lovastatin—atherosclerosis	0.00104	0.0136	CcSEcCtD
Bezafibrate—Transaminases increased—Ezetimibe—atherosclerosis	0.00102	0.0134	CcSEcCtD
Bezafibrate—Creatine phosphokinase increased—Pravastatin—atherosclerosis	0.00102	0.0133	CcSEcCtD
Bezafibrate—Cholelithiasis—Ezetimibe—atherosclerosis	0.001	0.0131	CcSEcCtD
Bezafibrate—PPARG—endothelium—atherosclerosis	0.000989	0.053	CbGeAlD
Bezafibrate—Transaminases increased—Simvastatin—atherosclerosis	0.000975	0.0127	CcSEcCtD
Bezafibrate—Blood creatine phosphokinase increased—Lovastatin—atherosclerosis	0.000922	0.012	CcSEcCtD
Bezafibrate—PPARG—blood vessel—atherosclerosis	0.000912	0.0489	CbGeAlD
Bezafibrate—Blood creatine phosphokinase increased—Ezetimibe—atherosclerosis	0.000904	0.0118	CcSEcCtD
Bezafibrate—Transaminases increased—Pravastatin—atherosclerosis	0.000882	0.0115	CcSEcCtD
Bezafibrate—Cholelithiasis—Niacin—atherosclerosis	0.000876	0.0114	CcSEcCtD
Bezafibrate—Blood creatine phosphokinase increased—Simvastatin—atherosclerosis	0.000862	0.0113	CcSEcCtD
Bezafibrate—PPARA—connective tissue—atherosclerosis	0.000851	0.0456	CbGeAlD
Bezafibrate—Rhabdomyolysis—Rosuvastatin—atherosclerosis	0.000846	0.0111	CcSEcCtD
Bezafibrate—Blood creatine phosphokinase increased—Pravastatin—atherosclerosis	0.000779	0.0102	CcSEcCtD
Bezafibrate—PPARD—adipose tissue—atherosclerosis	0.000766	0.0411	CbGeAlD
Bezafibrate—PPARA—cardiovascular system—atherosclerosis	0.00074	0.0397	CbGeAlD
Bezafibrate—Cholestasis—Niacin—atherosclerosis	0.000717	0.00937	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Lovastatin—atherosclerosis	0.000717	0.00937	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Ezetimibe—atherosclerosis	0.000703	0.00919	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Simvastatin—atherosclerosis	0.000671	0.00876	CcSEcCtD
Bezafibrate—PPARA—adipose tissue—atherosclerosis	0.000653	0.035	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Lovastatin—atherosclerosis	0.000634	0.00829	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Ezetimibe—atherosclerosis	0.000622	0.00813	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Niacin—atherosclerosis	0.000616	0.00804	CcSEcCtD
Bezafibrate—Rhabdomyolysis—Pravastatin—atherosclerosis	0.000606	0.00792	CcSEcCtD
Bezafibrate—Phosphatase alkaline increased—Simvastatin—atherosclerosis	0.000593	0.00775	CcSEcCtD
Bezafibrate—Renal failure acute—Rosuvastatin—atherosclerosis	0.000588	0.00769	CcSEcCtD
Bezafibrate—Fenofibrate—PPARA—atherosclerosis	0.000584	0.188	CrCbGaD
Bezafibrate—HMGCR—connective tissue—atherosclerosis	0.000566	0.0304	CbGeAlD
Bezafibrate—PPARD—liver—atherosclerosis	0.000537	0.0288	CbGeAlD
Bezafibrate—Phosphatase alkaline increased—Pravastatin—atherosclerosis	0.000536	0.00701	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Lovastatin—atherosclerosis	0.000529	0.00692	CcSEcCtD
Bezafibrate—Photosensitivity—Lovastatin—atherosclerosis	0.000524	0.00685	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Ezetimibe—atherosclerosis	0.000519	0.00678	CcSEcCtD
Bezafibrate—Vascular purpura—Lovastatin—atherosclerosis	0.000515	0.00673	CcSEcCtD
Bezafibrate—Photosensitivity—Ezetimibe—atherosclerosis	0.000514	0.00672	CcSEcCtD
Bezafibrate—Indomethacin—PLA2G2A—atherosclerosis	0.000511	0.164	CrCbGaD
Bezafibrate—Blood alkaline phosphatase increased—Simvastatin—atherosclerosis	0.000495	0.00647	CcSEcCtD
Bezafibrate—HMGCR—cardiovascular system—atherosclerosis	0.000493	0.0264	CbGeAlD
Bezafibrate—Photosensitivity—Simvastatin—atherosclerosis	0.00049	0.00641	CcSEcCtD
Bezafibrate—Vascular purpura—Simvastatin—atherosclerosis	0.000481	0.00629	CcSEcCtD
Bezafibrate—Eczema—Simvastatin—atherosclerosis	0.000479	0.00626	CcSEcCtD
Bezafibrate—Muscular weakness—Rosuvastatin—atherosclerosis	0.000479	0.00626	CcSEcCtD
Bezafibrate—Purpura—Lovastatin—atherosclerosis	0.000478	0.00624	CcSEcCtD
Bezafibrate—Influenza—Rosuvastatin—atherosclerosis	0.00047	0.00614	CcSEcCtD
Bezafibrate—PPARG—connective tissue—atherosclerosis	0.000468	0.0251	CbGeAlD
Bezafibrate—PPARA—liver—atherosclerosis	0.000458	0.0245	CbGeAlD
Bezafibrate—Bronchitis—Rosuvastatin—atherosclerosis	0.000452	0.0059	CcSEcCtD
Bezafibrate—Blood alkaline phosphatase increased—Pravastatin—atherosclerosis	0.000448	0.00585	CcSEcCtD
Bezafibrate—Purpura—Simvastatin—atherosclerosis	0.000447	0.00584	CcSEcCtD
Bezafibrate—Photosensitivity—Pravastatin—atherosclerosis	0.000443	0.00579	CcSEcCtD
Bezafibrate—Eczema—Niacin—atherosclerosis	0.00044	0.00575	CcSEcCtD
Bezafibrate—Vascular purpura—Pravastatin—atherosclerosis	0.000435	0.00569	CcSEcCtD
Bezafibrate—HMGCR—adipose tissue—atherosclerosis	0.000434	0.0233	CbGeAlD
Bezafibrate—Renal failure acute—Pravastatin—atherosclerosis	0.000422	0.00551	CcSEcCtD
Bezafibrate—Liver function test abnormal—Ezetimibe—atherosclerosis	0.000417	0.00545	CcSEcCtD
Bezafibrate—Balsalazide—ALOX5—atherosclerosis	0.000416	0.134	CrCbGaD
Bezafibrate—Toxic epidermal necrolysis—Lovastatin—atherosclerosis	0.000415	0.00542	CcSEcCtD
Bezafibrate—Cramp muscle—Lovastatin—atherosclerosis	0.000415	0.00542	CcSEcCtD
Bezafibrate—PPARG—cardiovascular system—atherosclerosis	0.000407	0.0218	CbGeAlD
Bezafibrate—Aspartate aminotransferase increased—Ezetimibe—atherosclerosis	0.000407	0.00531	CcSEcCtD
Bezafibrate—Cramp muscle—Ezetimibe—atherosclerosis	0.000407	0.00531	CcSEcCtD
Bezafibrate—Clofibrate—PPARA—atherosclerosis	0.000405	0.13	CrCbGaD
Bezafibrate—Purpura—Pravastatin—atherosclerosis	0.000404	0.00528	CcSEcCtD
Bezafibrate—Gastritis—Ezetimibe—atherosclerosis	0.0004	0.00522	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Ezetimibe—atherosclerosis	0.000398	0.0052	CcSEcCtD
Bezafibrate—Muscular weakness—Ezetimibe—atherosclerosis	0.000398	0.0052	CcSEcCtD
Bezafibrate—Influenza—Lovastatin—atherosclerosis	0.000398	0.0052	CcSEcCtD
Bezafibrate—Influenza—Ezetimibe—atherosclerosis	0.00039	0.0051	CcSEcCtD
Bezafibrate—Migraine—Niacin—atherosclerosis	0.000389	0.00509	CcSEcCtD
Bezafibrate—Cramp muscle—Simvastatin—atherosclerosis	0.000388	0.00507	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Simvastatin—atherosclerosis	0.000388	0.00507	CcSEcCtD
Bezafibrate—Gastritis—Simvastatin—atherosclerosis	0.000381	0.00498	CcSEcCtD
Bezafibrate—Muscular weakness—Simvastatin—atherosclerosis	0.00038	0.00496	CcSEcCtD
Bezafibrate—Pharyngitis—Rosuvastatin—atherosclerosis	0.000373	0.00487	CcSEcCtD
Bezafibrate—Erectile dysfunction—Lovastatin—atherosclerosis	0.000367	0.00479	CcSEcCtD
Bezafibrate—Liver function test abnormal—Niacin—atherosclerosis	0.000365	0.00477	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Lovastatin—atherosclerosis	0.000363	0.00475	CcSEcCtD
Bezafibrate—Erectile dysfunction—Ezetimibe—atherosclerosis	0.000359	0.0047	CcSEcCtD
Bezafibrate—Liver function test abnormal—Pravastatin—atherosclerosis	0.000359	0.0047	CcSEcCtD
Bezafibrate—PPARG—adipose tissue—atherosclerosis	0.000359	0.0192	CbGeAlD
Bezafibrate—Bronchitis—Simvastatin—atherosclerosis	0.000358	0.00468	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Ezetimibe—atherosclerosis	0.000356	0.00466	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Lovastatin—atherosclerosis	0.000352	0.0046	CcSEcCtD
Bezafibrate—Cramp muscle—Pravastatin—atherosclerosis	0.000351	0.00458	CcSEcCtD
Bezafibrate—Toxic epidermal necrolysis—Pravastatin—atherosclerosis	0.000351	0.00458	CcSEcCtD
Bezafibrate—Muscular weakness—Niacin—atherosclerosis	0.000349	0.00456	CcSEcCtD
Bezafibrate—Alanine aminotransferase increased—Pravastatin—atherosclerosis	0.000343	0.00449	CcSEcCtD
Bezafibrate—Muscular weakness—Pravastatin—atherosclerosis	0.000343	0.00449	CcSEcCtD
Bezafibrate—Erectile dysfunction—Simvastatin—atherosclerosis	0.000343	0.00448	CcSEcCtD
Bezafibrate—Influenza—Niacin—atherosclerosis	0.000342	0.00447	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Simvastatin—atherosclerosis	0.00034	0.00444	CcSEcCtD
Bezafibrate—Influenza—Pravastatin—atherosclerosis	0.000337	0.0044	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Simvastatin—atherosclerosis	0.000329	0.0043	CcSEcCtD
Bezafibrate—Bronchitis—Niacin—atherosclerosis	0.000329	0.00429	CcSEcCtD
Bezafibrate—Flatulence—Rosuvastatin—atherosclerosis	0.000322	0.00421	CcSEcCtD
Bezafibrate—Erectile dysfunction—Niacin—atherosclerosis	0.000315	0.00411	CcSEcCtD
Bezafibrate—Pharyngitis—Ezetimibe—atherosclerosis	0.00031	0.00405	CcSEcCtD
Bezafibrate—Erectile dysfunction—Pravastatin—atherosclerosis	0.00031	0.00405	CcSEcCtD
Bezafibrate—Photosensitivity reaction—Pravastatin—atherosclerosis	0.000307	0.00401	CcSEcCtD
Bezafibrate—HMGCR—liver—atherosclerosis	0.000305	0.0163	CbGeAlD
Bezafibrate—Erythema multiforme—Lovastatin—atherosclerosis	0.000301	0.00394	CcSEcCtD
Bezafibrate—Stevens-Johnson syndrome—Pravastatin—atherosclerosis	0.000297	0.00389	CcSEcCtD
Bezafibrate—Acute coronary syndrome—Pravastatin—atherosclerosis	0.000296	0.00386	CcSEcCtD
Bezafibrate—Erythema multiforme—Ezetimibe—atherosclerosis	0.000295	0.00386	CcSEcCtD
Bezafibrate—Myocardial infarction—Pravastatin—atherosclerosis	0.000294	0.00384	CcSEcCtD
Bezafibrate—SLCO1B1—liver—atherosclerosis	0.000292	0.0156	CbGeAlD
Bezafibrate—Erythema multiforme—Simvastatin—atherosclerosis	0.000282	0.00368	CcSEcCtD
Bezafibrate—Alopecia—Lovastatin—atherosclerosis	0.000281	0.00368	CcSEcCtD
Bezafibrate—Myalgia—Rosuvastatin—atherosclerosis	0.000279	0.00364	CcSEcCtD
Bezafibrate—Alopecia—Ezetimibe—atherosclerosis	0.000276	0.00361	CcSEcCtD
Bezafibrate—Flatulence—Lovastatin—atherosclerosis	0.000273	0.00357	CcSEcCtD
Bezafibrate—Erythema—Ezetimibe—atherosclerosis	0.000272	0.00355	CcSEcCtD
Bezafibrate—Flatulence—Ezetimibe—atherosclerosis	0.000268	0.0035	CcSEcCtD
Bezafibrate—Pharyngitis—Pravastatin—atherosclerosis	0.000267	0.00349	CcSEcCtD
Bezafibrate—Muscle spasms—Lovastatin—atherosclerosis	0.000267	0.00348	CcSEcCtD
Bezafibrate—Infection—Rosuvastatin—atherosclerosis	0.000265	0.00347	CcSEcCtD
Bezafibrate—Glyburide—ABCA1—atherosclerosis	0.000265	0.0852	CrCbGaD
Bezafibrate—Alopecia—Simvastatin—atherosclerosis	0.000263	0.00344	CcSEcCtD
Bezafibrate—Muscle spasms—Ezetimibe—atherosclerosis	0.000261	0.00342	CcSEcCtD
Bezafibrate—Thrombocytopenia—Rosuvastatin—atherosclerosis	0.000261	0.00342	CcSEcCtD
Bezafibrate—Erythema—Simvastatin—atherosclerosis	0.000259	0.00339	CcSEcCtD
Bezafibrate—Flatulence—Simvastatin—atherosclerosis	0.000256	0.00334	CcSEcCtD
Bezafibrate—Erythema multiforme—Pravastatin—atherosclerosis	0.000255	0.00333	CcSEcCtD
Bezafibrate—PPARG—liver—atherosclerosis	0.000252	0.0135	CbGeAlD
Bezafibrate—Anaemia—Ezetimibe—atherosclerosis	0.000251	0.00328	CcSEcCtD
Bezafibrate—Muscle spasms—Simvastatin—atherosclerosis	0.000249	0.00326	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Rosuvastatin—atherosclerosis	0.000243	0.00318	CcSEcCtD
Bezafibrate—Alopecia—Niacin—atherosclerosis	0.000242	0.00316	CcSEcCtD
Bezafibrate—Insomnia—Rosuvastatin—atherosclerosis	0.000242	0.00316	CcSEcCtD
Bezafibrate—Anaemia—Simvastatin—atherosclerosis	0.00024	0.00313	CcSEcCtD
Bezafibrate—Erythema—Niacin—atherosclerosis	0.000238	0.00311	CcSEcCtD
Bezafibrate—Alopecia—Pravastatin—atherosclerosis	0.000238	0.00311	CcSEcCtD
Bezafibrate—Balsalazide—PPARG—atherosclerosis	0.000238	0.0764	CrCbGaD
Bezafibrate—Myalgia—Lovastatin—atherosclerosis	0.000236	0.00308	CcSEcCtD
Bezafibrate—Dyspepsia—Rosuvastatin—atherosclerosis	0.000235	0.00307	CcSEcCtD
Bezafibrate—Flatulence—Niacin—atherosclerosis	0.000235	0.00307	CcSEcCtD
Bezafibrate—Myalgia—Ezetimibe—atherosclerosis	0.000232	0.00303	CcSEcCtD
Bezafibrate—Flatulence—Pravastatin—atherosclerosis	0.000231	0.00302	CcSEcCtD
Bezafibrate—Muscle spasms—Niacin—atherosclerosis	0.000229	0.00299	CcSEcCtD
Bezafibrate—Pain—Rosuvastatin—atherosclerosis	0.000228	0.00298	CcSEcCtD
Bezafibrate—Constipation—Rosuvastatin—atherosclerosis	0.000228	0.00298	CcSEcCtD
Bezafibrate—Muscle spasms—Pravastatin—atherosclerosis	0.000225	0.00295	CcSEcCtD
Bezafibrate—Infection—Lovastatin—atherosclerosis	0.000225	0.00294	CcSEcCtD
Bezafibrate—Thrombocytopenia—Lovastatin—atherosclerosis	0.000222	0.0029	CcSEcCtD
Bezafibrate—Myalgia—Simvastatin—atherosclerosis	0.000221	0.00289	CcSEcCtD
Bezafibrate—Infection—Ezetimibe—atherosclerosis	0.000221	0.00288	CcSEcCtD
Bezafibrate—Indomethacin—PPARA—atherosclerosis	0.000219	0.0703	CrCbGaD
Bezafibrate—CYP1A1—adipose tissue—atherosclerosis	0.000218	0.0117	CbGeAlD
Bezafibrate—Gastrointestinal pain—Rosuvastatin—atherosclerosis	0.000218	0.00285	CcSEcCtD
Bezafibrate—Thrombocytopenia—Ezetimibe—atherosclerosis	0.000217	0.00284	CcSEcCtD
Bezafibrate—Anaemia—Pravastatin—atherosclerosis	0.000217	0.00283	CcSEcCtD
Bezafibrate—Urticaria—Rosuvastatin—atherosclerosis	0.000212	0.00277	CcSEcCtD
Bezafibrate—Abdominal pain—Rosuvastatin—atherosclerosis	0.000211	0.00276	CcSEcCtD
Bezafibrate—Infection—Simvastatin—atherosclerosis	0.00021	0.00275	CcSEcCtD
Bezafibrate—Thrombocytopenia—Simvastatin—atherosclerosis	0.000207	0.00271	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Lovastatin—atherosclerosis	0.000206	0.00269	CcSEcCtD
Bezafibrate—Insomnia—Lovastatin—atherosclerosis	0.000205	0.00267	CcSEcCtD
Bezafibrate—Myalgia—Niacin—atherosclerosis	0.000203	0.00265	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Ezetimibe—atherosclerosis	0.000202	0.00264	CcSEcCtD
Bezafibrate—Insomnia—Ezetimibe—atherosclerosis	0.000201	0.00262	CcSEcCtD
Bezafibrate—Myalgia—Pravastatin—atherosclerosis	0.0002	0.00261	CcSEcCtD
Bezafibrate—Dyspepsia—Lovastatin—atherosclerosis	0.000199	0.0026	CcSEcCtD
Bezafibrate—Hypersensitivity—Rosuvastatin—atherosclerosis	0.000197	0.00257	CcSEcCtD
Bezafibrate—Dyspepsia—Ezetimibe—atherosclerosis	0.000195	0.00255	CcSEcCtD
Bezafibrate—Constipation—Lovastatin—atherosclerosis	0.000194	0.00253	CcSEcCtD
Bezafibrate—Pain—Lovastatin—atherosclerosis	0.000194	0.00253	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Simvastatin—atherosclerosis	0.000193	0.00252	CcSEcCtD
Bezafibrate—Insomnia—Simvastatin—atherosclerosis	0.000191	0.0025	CcSEcCtD
Bezafibrate—Infection—Pravastatin—atherosclerosis	0.00019	0.00248	CcSEcCtD
Bezafibrate—Constipation—Ezetimibe—atherosclerosis	0.00019	0.00248	CcSEcCtD
Bezafibrate—Pain—Ezetimibe—atherosclerosis	0.00019	0.00248	CcSEcCtD
Bezafibrate—Pruritus—Rosuvastatin—atherosclerosis	0.000189	0.00247	CcSEcCtD
Bezafibrate—Thrombocytopenia—Pravastatin—atherosclerosis	0.000187	0.00245	CcSEcCtD
Bezafibrate—Dyspepsia—Simvastatin—atherosclerosis	0.000186	0.00243	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Lovastatin—atherosclerosis	0.000185	0.00242	CcSEcCtD
Bezafibrate—Diarrhoea—Rosuvastatin—atherosclerosis	0.000183	0.00239	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Ezetimibe—atherosclerosis	0.000181	0.00237	CcSEcCtD
Bezafibrate—Pain—Simvastatin—atherosclerosis	0.000181	0.00237	CcSEcCtD
Bezafibrate—Constipation—Simvastatin—atherosclerosis	0.000181	0.00237	CcSEcCtD
Bezafibrate—Urticaria—Lovastatin—atherosclerosis	0.00018	0.00235	CcSEcCtD
Bezafibrate—Abdominal pain—Lovastatin—atherosclerosis	0.000179	0.00234	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Niacin—atherosclerosis	0.000177	0.00231	CcSEcCtD
Bezafibrate—Dizziness—Rosuvastatin—atherosclerosis	0.000177	0.00231	CcSEcCtD
Bezafibrate—Urticaria—Ezetimibe—atherosclerosis	0.000176	0.0023	CcSEcCtD
Bezafibrate—Insomnia—Niacin—atherosclerosis	0.000176	0.0023	CcSEcCtD
Bezafibrate—Abdominal pain—Ezetimibe—atherosclerosis	0.000175	0.00229	CcSEcCtD
Bezafibrate—Musculoskeletal discomfort—Pravastatin—atherosclerosis	0.000174	0.00228	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Simvastatin—atherosclerosis	0.000173	0.00226	CcSEcCtD
Bezafibrate—Insomnia—Pravastatin—atherosclerosis	0.000173	0.00226	CcSEcCtD
Bezafibrate—Dyspepsia—Niacin—atherosclerosis	0.000171	0.00224	CcSEcCtD
Bezafibrate—Dyspepsia—Pravastatin—atherosclerosis	0.000168	0.0022	CcSEcCtD
Bezafibrate—Rash—Rosuvastatin—atherosclerosis	0.000168	0.0022	CcSEcCtD
Bezafibrate—Dermatitis—Rosuvastatin—atherosclerosis	0.000168	0.0022	CcSEcCtD
Bezafibrate—Urticaria—Simvastatin—atherosclerosis	0.000168	0.0022	CcSEcCtD
Bezafibrate—Abdominal pain—Simvastatin—atherosclerosis	0.000167	0.00219	CcSEcCtD
Bezafibrate—Headache—Rosuvastatin—atherosclerosis	0.000167	0.00219	CcSEcCtD
Bezafibrate—Hypersensitivity—Lovastatin—atherosclerosis	0.000167	0.00218	CcSEcCtD
Bezafibrate—Pain—Niacin—atherosclerosis	0.000166	0.00217	CcSEcCtD
Bezafibrate—CYP2C8—liver—atherosclerosis	0.000166	0.0089	CbGeAlD
Bezafibrate—Pain—Pravastatin—atherosclerosis	0.000164	0.00214	CcSEcCtD
Bezafibrate—Constipation—Pravastatin—atherosclerosis	0.000164	0.00214	CcSEcCtD
Bezafibrate—Hypersensitivity—Ezetimibe—atherosclerosis	0.000164	0.00214	CcSEcCtD
Bezafibrate—Pruritus—Lovastatin—atherosclerosis	0.00016	0.00209	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Niacin—atherosclerosis	0.000159	0.00208	CcSEcCtD
Bezafibrate—Nausea—Rosuvastatin—atherosclerosis	0.000159	0.00207	CcSEcCtD
Bezafibrate—Pruritus—Ezetimibe—atherosclerosis	0.000157	0.00205	CcSEcCtD
Bezafibrate—Gastrointestinal pain—Pravastatin—atherosclerosis	0.000156	0.00204	CcSEcCtD
Bezafibrate—Hypersensitivity—Simvastatin—atherosclerosis	0.000156	0.00204	CcSEcCtD
Bezafibrate—Diarrhoea—Lovastatin—atherosclerosis	0.000155	0.00202	CcSEcCtD
Bezafibrate—Urticaria—Niacin—atherosclerosis	0.000154	0.00202	CcSEcCtD
Bezafibrate—Abdominal pain—Niacin—atherosclerosis	0.000154	0.00201	CcSEcCtD
Bezafibrate—CYP1A1—liver—atherosclerosis	0.000153	0.00821	CbGeAlD
Bezafibrate—Urticaria—Pravastatin—atherosclerosis	0.000152	0.00199	CcSEcCtD
Bezafibrate—Diarrhoea—Ezetimibe—atherosclerosis	0.000152	0.00198	CcSEcCtD
Bezafibrate—Indomethacin—CXCL8—atherosclerosis	0.000152	0.0487	CrCbGaD
Bezafibrate—Abdominal pain—Pravastatin—atherosclerosis	0.000151	0.00198	CcSEcCtD
Bezafibrate—Pruritus—Simvastatin—atherosclerosis	0.00015	0.00196	CcSEcCtD
Bezafibrate—Dizziness—Lovastatin—atherosclerosis	0.00015	0.00196	CcSEcCtD
Bezafibrate—Dizziness—Ezetimibe—atherosclerosis	0.000147	0.00192	CcSEcCtD
Bezafibrate—Diarrhoea—Simvastatin—atherosclerosis	0.000145	0.00189	CcSEcCtD
Bezafibrate—Hypersensitivity—Niacin—atherosclerosis	0.000143	0.00187	CcSEcCtD
Bezafibrate—Rash—Lovastatin—atherosclerosis	0.000143	0.00186	CcSEcCtD
Bezafibrate—Dermatitis—Lovastatin—atherosclerosis	0.000143	0.00186	CcSEcCtD
Bezafibrate—Headache—Lovastatin—atherosclerosis	0.000142	0.00185	CcSEcCtD
Bezafibrate—Hypersensitivity—Pravastatin—atherosclerosis	0.000141	0.00184	CcSEcCtD
Bezafibrate—Dizziness—Simvastatin—atherosclerosis	0.00014	0.00183	CcSEcCtD
Bezafibrate—Rash—Ezetimibe—atherosclerosis	0.00014	0.00183	CcSEcCtD
Bezafibrate—Dermatitis—Ezetimibe—atherosclerosis	0.00014	0.00183	CcSEcCtD
Bezafibrate—Headache—Ezetimibe—atherosclerosis	0.000139	0.00182	CcSEcCtD
Bezafibrate—Pruritus—Niacin—atherosclerosis	0.000138	0.0018	CcSEcCtD
Bezafibrate—Pruritus—Pravastatin—atherosclerosis	0.000135	0.00177	CcSEcCtD
Bezafibrate—Nausea—Lovastatin—atherosclerosis	0.000134	0.00176	CcSEcCtD
Bezafibrate—Rash—Simvastatin—atherosclerosis	0.000133	0.00174	CcSEcCtD
Bezafibrate—Dermatitis—Simvastatin—atherosclerosis	0.000133	0.00174	CcSEcCtD
Bezafibrate—Diarrhoea—Niacin—atherosclerosis	0.000133	0.00174	CcSEcCtD
Bezafibrate—Headache—Simvastatin—atherosclerosis	0.000133	0.00173	CcSEcCtD
Bezafibrate—Nausea—Ezetimibe—atherosclerosis	0.000132	0.00172	CcSEcCtD
Bezafibrate—Diarrhoea—Pravastatin—atherosclerosis	0.000131	0.00171	CcSEcCtD
Bezafibrate—Dizziness—Niacin—atherosclerosis	0.000129	0.00168	CcSEcCtD
Bezafibrate—Dizziness—Pravastatin—atherosclerosis	0.000127	0.00165	CcSEcCtD
Bezafibrate—Nausea—Simvastatin—atherosclerosis	0.000126	0.00164	CcSEcCtD
Bezafibrate—Rash—Niacin—atherosclerosis	0.000123	0.0016	CcSEcCtD
Bezafibrate—Dermatitis—Niacin—atherosclerosis	0.000122	0.0016	CcSEcCtD
Bezafibrate—Headache—Niacin—atherosclerosis	0.000122	0.00159	CcSEcCtD
Bezafibrate—Rash—Pravastatin—atherosclerosis	0.000121	0.00158	CcSEcCtD
Bezafibrate—Dermatitis—Pravastatin—atherosclerosis	0.000121	0.00158	CcSEcCtD
Bezafibrate—Headache—Pravastatin—atherosclerosis	0.00012	0.00157	CcSEcCtD
Bezafibrate—Nausea—Niacin—atherosclerosis	0.000115	0.00151	CcSEcCtD
Bezafibrate—Nausea—Pravastatin—atherosclerosis	0.000114	0.00149	CcSEcCtD
Bezafibrate—CYP3A4—liver—atherosclerosis	0.000112	0.00603	CbGeAlD
Bezafibrate—Indomethacin—PPARG—atherosclerosis	0.000105	0.0337	CrCbGaD
Bezafibrate—Balsalazide—PTGS2—atherosclerosis	0.0001	0.0323	CrCbGaD
Bezafibrate—Indomethacin—PTGS2—atherosclerosis	4.43e-05	0.0142	CrCbGaD
Bezafibrate—Indomethacin—ALB—atherosclerosis	3.94e-05	0.0127	CrCbGaD
Bezafibrate—Glyburide—ALB—atherosclerosis	3.56e-05	0.0114	CrCbGaD
Bezafibrate—SLCO1B1—Metabolism—LDLR—atherosclerosis	7.56e-06	0.000108	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ABCA1—atherosclerosis	7.56e-06	0.000108	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—CAV1—atherosclerosis	7.51e-06	0.000107	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MMP9—atherosclerosis	7.51e-06	0.000107	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—APOA1—atherosclerosis	7.5e-06	0.000107	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LCAT—atherosclerosis	7.49e-06	0.000107	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—FABP4—atherosclerosis	7.49e-06	0.000107	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—MTHFR—atherosclerosis	7.45e-06	0.000106	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—NFKB1—atherosclerosis	7.43e-06	0.000106	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CETP—atherosclerosis	7.38e-06	0.000105	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA4—atherosclerosis	7.35e-06	0.000105	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCG1—atherosclerosis	7.3e-06	0.000104	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP7A1—atherosclerosis	7.22e-06	0.000103	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—ALB—atherosclerosis	7.13e-06	0.000102	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AGT—atherosclerosis	7.08e-06	0.000101	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—SCARB1—atherosclerosis	7.07e-06	0.000101	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—SERPINE1—atherosclerosis	7e-06	9.99e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOE—atherosclerosis	6.94e-06	9.9e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	6.88e-06	9.82e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.88e-06	9.82e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—CAV1—atherosclerosis	6.87e-06	9.81e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LCAT—atherosclerosis	6.87e-06	9.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—FABP4—atherosclerosis	6.87e-06	9.8e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—APOA1—atherosclerosis	6.86e-06	9.78e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PIK3CG—atherosclerosis	6.84e-06	9.77e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—NOS3—atherosclerosis	6.82e-06	9.73e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—VEGFA—atherosclerosis	6.75e-06	9.63e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA4—atherosclerosis	6.74e-06	9.62e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—PPARA—atherosclerosis	6.74e-06	9.61e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—STAT3—atherosclerosis	6.68e-06	9.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMGCR—atherosclerosis	6.68e-06	9.53e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CYP27A1—atherosclerosis	6.68e-06	9.53e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP7A1—atherosclerosis	6.62e-06	9.45e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PPARG—atherosclerosis	6.61e-06	9.43e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.57e-06	9.38e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Transmembrane transport of small molecules—ALB—atherosclerosis	6.55e-06	9.34e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—IL6—atherosclerosis	6.51e-06	9.29e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—HMOX1—atherosclerosis	6.48e-06	9.25e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—INS—atherosclerosis	6.48e-06	9.24e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	6.41e-06	9.15e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—MAPK3—atherosclerosis	6.38e-06	9.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA2—atherosclerosis	6.33e-06	9.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLA2G2A—atherosclerosis	6.33e-06	9.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALOX5AP—atherosclerosis	6.33e-06	9.03e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALOX15—atherosclerosis	6.33e-06	9.03e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOB—atherosclerosis	6.31e-06	9e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PIK3CG—atherosclerosis	6.26e-06	8.93e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCG5—atherosclerosis	6.25e-06	8.92e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	6.24e-06	8.91e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—PTGS2—atherosclerosis	6.24e-06	8.9e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOB—atherosclerosis	6.21e-06	8.86e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TGFB1—atherosclerosis	6.19e-06	8.83e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CYP27A1—atherosclerosis	6.12e-06	8.73e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—ESR1—atherosclerosis	6.1e-06	8.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	6.08e-06	8.68e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GSTM1—atherosclerosis	6.04e-06	8.62e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PPARG—atherosclerosis	6.04e-06	8.62e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LPA—atherosclerosis	6.04e-06	8.61e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—LPL—atherosclerosis	6.03e-06	8.6e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	6.02e-06	8.59e-05	CbGpPWpGaD
Bezafibrate—PPARA—Developmental Biology—AKT1—atherosclerosis	6.01e-06	8.57e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—MAPK3—atherosclerosis	5.98e-06	8.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ABCA1—atherosclerosis	5.95e-06	8.49e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—ALB—atherosclerosis	5.94e-06	8.48e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—LPL—atherosclerosis	5.93e-06	8.46e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—INS—atherosclerosis	5.93e-06	8.46e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—atherosclerosis	5.88e-06	8.39e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—BGN—atherosclerosis	5.85e-06	8.34e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.81e-06	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALOX5AP—atherosclerosis	5.8e-06	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALOX15—atherosclerosis	5.8e-06	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA2—atherosclerosis	5.8e-06	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLA2G2A—atherosclerosis	5.8e-06	8.28e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA5—atherosclerosis	5.79e-06	8.26e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—GPX1—atherosclerosis	5.79e-06	8.26e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—TNF—atherosclerosis	5.78e-06	8.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCG5—atherosclerosis	5.73e-06	8.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CD36—atherosclerosis	5.73e-06	8.17e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLTP—atherosclerosis	5.72e-06	8.16e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—NOS3—atherosclerosis	5.68e-06	8.11e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CD36—atherosclerosis	5.63e-06	8.04e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.62e-06	8.02e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PLA2G1B—atherosclerosis	5.57e-06	7.95e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LPA—atherosclerosis	5.54e-06	7.9e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.51e-06	7.86e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5.46e-06	7.79e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	5.45e-06	7.77e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—ALB—atherosclerosis	5.43e-06	7.75e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALOX5—atherosclerosis	5.38e-06	7.68e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—BGN—atherosclerosis	5.36e-06	7.65e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—MTHFR—atherosclerosis	5.34e-06	7.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARA—atherosclerosis	5.32e-06	7.59e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA5—atherosclerosis	5.31e-06	7.57e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PPARA—atherosclerosis	5.24e-06	7.47e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—NOS3—atherosclerosis	5.2e-06	7.41e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—PTGS2—atherosclerosis	5.2e-06	7.41e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—AGT—atherosclerosis	5.15e-06	7.36e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PLA2G1B—atherosclerosis	5.11e-06	7.29e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—HMOX1—atherosclerosis	5.11e-06	7.29e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AGT—atherosclerosis	5.07e-06	7.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOE—atherosclerosis	5.05e-06	7.21e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—SERPINE1—atherosclerosis	5.02e-06	7.16e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—atherosclerosis	5e-06	7.14e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—APOA1—atherosclerosis	4.99e-06	7.12e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.97e-06	7.09e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOE—atherosclerosis	4.97e-06	7.09e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG8—atherosclerosis	4.96e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LTA4H—atherosclerosis	4.96e-06	7.08e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALOX5—atherosclerosis	4.93e-06	7.04e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—CAV1—atherosclerosis	4.93e-06	7.03e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—APOA1—atherosclerosis	4.91e-06	7.01e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOB—atherosclerosis	4.89e-06	6.98e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NAMPT—atherosclerosis	4.83e-06	6.89e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.8e-06	6.85e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LIPC—atherosclerosis	4.8e-06	6.84e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOC3—atherosclerosis	4.77e-06	6.8e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GSTM1—atherosclerosis	4.76e-06	6.79e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—PTGS2—atherosclerosis	4.75e-06	6.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LDLR—atherosclerosis	4.74e-06	6.76e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—LPL—atherosclerosis	4.67e-06	6.66e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—IL6—atherosclerosis	4.67e-06	6.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CETP—atherosclerosis	4.63e-06	6.6e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—atherosclerosis	4.56e-06	6.5e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—GPX1—atherosclerosis	4.56e-06	6.5e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—MAPK3—atherosclerosis	4.55e-06	6.5e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PIK3CG—atherosclerosis	4.49e-06	6.4e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CD36—atherosclerosis	4.44e-06	6.33e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—SCARB1—atherosclerosis	4.43e-06	6.32e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NAMPT—atherosclerosis	4.43e-06	6.31e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—atherosclerosis	4.4e-06	6.28e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LIPC—atherosclerosis	4.4e-06	6.27e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOC3—atherosclerosis	4.37e-06	6.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LDLR—atherosclerosis	4.34e-06	6.2e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	4.31e-06	6.16e-05	CbGpPWpGaD
Bezafibrate—PPARG—Developmental Biology—AKT1—atherosclerosis	4.3e-06	6.14e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—INS—atherosclerosis	4.25e-06	6.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CETP—atherosclerosis	4.24e-06	6.05e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—MTHFR—atherosclerosis	4.2e-06	6e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMGCR—atherosclerosis	4.18e-06	5.97e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARA—atherosclerosis	4.12e-06	5.89e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—SCARB1—atherosclerosis	4.06e-06	5.8e-05	CbGpPWpGaD
Bezafibrate—PPARD—Gene Expression—AKT1—atherosclerosis	4.03e-06	5.75e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AGT—atherosclerosis	3.99e-06	5.7e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—ALB—atherosclerosis	3.96e-06	5.64e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG1—atherosclerosis	3.92e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOE—atherosclerosis	3.91e-06	5.59e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—ALB—atherosclerosis	3.89e-06	5.56e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—CAV1—atherosclerosis	3.88e-06	5.53e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—APOA1—atherosclerosis	3.87e-06	5.52e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMGCR—atherosclerosis	3.84e-06	5.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.77e-06	5.39e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ABCA1—atherosclerosis	3.73e-06	5.32e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—NOS3—atherosclerosis	3.72e-06	5.31e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LCAT—atherosclerosis	3.69e-06	5.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—FABP4—atherosclerosis	3.69e-06	5.26e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA4—atherosclerosis	3.62e-06	5.16e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP7A1—atherosclerosis	3.55e-06	5.07e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PIK3CG—atherosclerosis	3.53e-06	5.04e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—atherosclerosis	3.46e-06	4.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ABCA1—atherosclerosis	3.42e-06	4.88e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PPARG—atherosclerosis	3.41e-06	4.87e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—PTGS2—atherosclerosis	3.41e-06	4.86e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—INS—atherosclerosis	3.34e-06	4.77e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CYP27A1—atherosclerosis	3.29e-06	4.69e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—MAPK3—atherosclerosis	3.26e-06	4.66e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—HMOX1—atherosclerosis	3.2e-06	4.57e-05	CbGpPWpGaD
Bezafibrate—PPARD—Metabolism—AKT1—atherosclerosis	3.14e-06	4.47e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	3.11e-06	4.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA2—atherosclerosis	3.11e-06	4.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	3.11e-06	4.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALOX15—atherosclerosis	3.11e-06	4.44e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCG5—atherosclerosis	3.08e-06	4.39e-05	CbGpPWpGaD
Bezafibrate—PPARA—Gene Expression—AKT1—atherosclerosis	3.07e-06	4.38e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—ALB—atherosclerosis	3.07e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOB—atherosclerosis	3.07e-06	4.37e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GSTM1—atherosclerosis	2.98e-06	4.25e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPA—atherosclerosis	2.97e-06	4.24e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—HMOX1—atherosclerosis	2.93e-06	4.19e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—NOS3—atherosclerosis	2.93e-06	4.18e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—LPL—atherosclerosis	2.93e-06	4.18e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—BGN—atherosclerosis	2.88e-06	4.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—GPX1—atherosclerosis	2.86e-06	4.07e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA5—atherosclerosis	2.85e-06	4.06e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOB—atherosclerosis	2.81e-06	4.01e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CD36—atherosclerosis	2.78e-06	3.97e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	2.74e-06	3.91e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GSTM1—atherosclerosis	2.73e-06	3.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—LPL—atherosclerosis	2.68e-06	3.83e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—PTGS2—atherosclerosis	2.68e-06	3.83e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALOX5—atherosclerosis	2.65e-06	3.78e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—MTHFR—atherosclerosis	2.64e-06	3.76e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—GPX1—atherosclerosis	2.62e-06	3.74e-05	CbGpPWpGaD
Bezafibrate—HMGCR—Metabolism—AKT1—atherosclerosis	2.61e-06	3.73e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARA—atherosclerosis	2.59e-06	3.69e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CD36—atherosclerosis	2.55e-06	3.64e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AGT—atherosclerosis	2.5e-06	3.57e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOE—atherosclerosis	2.45e-06	3.5e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—CAV1—atherosclerosis	2.43e-06	3.47e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—APOA1—atherosclerosis	2.43e-06	3.46e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—MTHFR—atherosclerosis	2.42e-06	3.45e-05	CbGpPWpGaD
Bezafibrate—PPARA—Metabolism—AKT1—atherosclerosis	2.39e-06	3.41e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NAMPT—atherosclerosis	2.38e-06	3.39e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARA—atherosclerosis	2.37e-06	3.38e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LIPC—atherosclerosis	2.36e-06	3.37e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOC3—atherosclerosis	2.35e-06	3.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LDLR—atherosclerosis	2.33e-06	3.33e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AGT—atherosclerosis	2.3e-06	3.28e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CETP—atherosclerosis	2.28e-06	3.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOE—atherosclerosis	2.25e-06	3.21e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—CAV1—atherosclerosis	2.23e-06	3.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—APOA1—atherosclerosis	2.22e-06	3.17e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PIK3CG—atherosclerosis	2.21e-06	3.16e-05	CbGpPWpGaD
Bezafibrate—PPARG—Gene Expression—AKT1—atherosclerosis	2.2e-06	3.14e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—SCARB1—atherosclerosis	2.18e-06	3.11e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PPARG—atherosclerosis	2.14e-06	3.05e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—INS—atherosclerosis	2.1e-06	2.99e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.06e-06	2.94e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PIK3CG—atherosclerosis	2.03e-06	2.9e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PPARG—atherosclerosis	1.96e-06	2.8e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—INS—atherosclerosis	1.92e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—ALB—atherosclerosis	1.92e-06	2.74e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—NOS3—atherosclerosis	1.84e-06	2.62e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ABCA1—atherosclerosis	1.84e-06	2.62e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—ALB—atherosclerosis	1.76e-06	2.51e-05	CbGpPWpGaD
Bezafibrate—PPARG—Metabolism—AKT1—atherosclerosis	1.71e-06	2.44e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—NOS3—atherosclerosis	1.69e-06	2.4e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—PTGS2—atherosclerosis	1.68e-06	2.4e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—HMOX1—atherosclerosis	1.57e-06	2.25e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—PTGS2—atherosclerosis	1.54e-06	2.2e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOB—atherosclerosis	1.51e-06	2.15e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GSTM1—atherosclerosis	1.47e-06	2.09e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—LPL—atherosclerosis	1.44e-06	2.06e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—GPX1—atherosclerosis	1.41e-06	2.01e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CD36—atherosclerosis	1.37e-06	1.95e-05	CbGpPWpGaD
Bezafibrate—SLCO1B1—Metabolism—AKT1—atherosclerosis	1.35e-06	1.92e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.3e-06	1.85e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARA—atherosclerosis	1.27e-06	1.82e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AGT—atherosclerosis	1.23e-06	1.76e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOE—atherosclerosis	1.21e-06	1.72e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—CAV1—atherosclerosis	1.2e-06	1.71e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—APOA1—atherosclerosis	1.19e-06	1.7e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.09e-06	1.55e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PPARG—atherosclerosis	1.05e-06	1.5e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—INS—atherosclerosis	1.03e-06	1.47e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—ALB—atherosclerosis	9.46e-07	1.35e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—NOS3—atherosclerosis	9.04e-07	1.29e-05	CbGpPWpGaD
Bezafibrate—CYP1A1—Metabolism—AKT1—atherosclerosis	8.45e-07	1.21e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—PTGS2—atherosclerosis	8.27e-07	1.18e-05	CbGpPWpGaD
Bezafibrate—CYP2C8—Metabolism—AKT1—atherosclerosis	7.75e-07	1.11e-05	CbGpPWpGaD
Bezafibrate—CYP3A4—Metabolism—AKT1—atherosclerosis	4.16e-07	5.93e-06	CbGpPWpGaD
